Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CVXGA 1

Next Previous
X
Search
Drug Profile

CVXGA 1

Alternative Names: BLB-101; CVXGA; CVXGA 1 - Blue Lake Biotechnology; Intranasal Parainfluenza Virus Type 5-SARS CoV-2 S Vaccine; PIV5-SARS CoV-2 vaccine

Latest Information Update: 19 Jun 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator CyanVac
  • Class COVID-19 vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II COVID 2019 infections

Most Recent Events

  • 13 Jun 2024 CyanVac plans a phase IIb trial in COVID-2019 infections (Prevention) (Intranasal) in 2024
  • 30 Jun 2023 Phase-II clinical trials in COVID-2019 infections (Prevention) in USA (Intranasal) (NCT05736835)
  • 20 Jun 2023 Blue Lake Biotechnology plans a phase II trial for COVID-2019 infections (In volunteers) (Intranasal) in the second quarter of 2023 (Blue Lake Biotechnology pipeline, June 2023)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top